Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2

British Journal of Pharmacology

Volumn 163, Issue 5, 2011, Pages 984-994

  Gan, J ^a,b   Greenwood, S M ^a   Cobb, S R ^b   Bushell, T J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

astrocyte; hippocampus; neuronal excitability; NMDA; proteinase activated receptor 2; synaptic transmission

Indexed keywords

IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; EXTRACELLULAR RECORDING; HIPPOCAMPUS; LONG TERM DEPRESSION; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; NEURONS; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, PAR-2; SYNAPTIC TRANSMISSION;

EID: 79958806098     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01293.x     Document Type: Article

References (39)

1. Afkhami-Goli A, Noorbakhsh F, Keller AJ, Vergnolle N, Westaway D, Jhamandas JH, et al,. (2007). Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J Immunol 179: 5493-5503.
2. 2+ signalling. Science 327: 1250-1254.
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
4. Almonte AG, Hamill CE, Chhatwal JP, Wingo TS, Barber JA, Lyuboslavsky PN, et al,. (2007). Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol Learn Mem 88: 295-304. (Pubitemid 47321213)
5. Anderson WW, Collingridge GL, (2007). Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods 162: 346-356. (Pubitemid 46527917)
6. Araque A, (2008). Astrocytes process synaptic information. Neuron Glia Biol 4: 3-10.
7. Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK, et al,. (2010). Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 30: 4590-4600.
8. Bushell TJ, (2007). The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol 581: 7-16.
9. Bushell TJ, Plevin R, Cobb S, Irving AJ, (2006). Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes. Neuropharmacology 50: 714-725.
10. D'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, et al,. (1998). Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46: 57-64.
11. Fiacco TA, Agulhon C, Taves SR, Petravicz J, Casper KB, Dong X, et al,. (2007). Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron 54: 611-626. (Pubitemid 46756143)
12. Fiacco TA, Agulhon C, McCarthy KD, (2009). Sorting out astrocyte physiology from pharmacology. Annu Rev Pharmacol Toxicol 49: 151-174.
13. Fonnum F, Johnsen A, Hassel B, (1997). Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 21: 106-113. (Pubitemid 27389646)
14. Gladding CM, Fitzjohn SM, Molnár E, (2009). Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms. Pharmacol Rev 61: 395-412.
15. Greenwood SM, Bushell TJ, (2010). Astrocytic activation and an inhibition of MAP kinases are required for proteinase-activated receptor-2-mediated protection from neurotoxicity. J Neurochem 113: 1471-1480.
16. Greenwood SM, Mizielinska SM, Frenguelli BG, Harvey J, Connolly CN, (2007). Mitochondrial dysfunction and dendritic beading during neuronal toxicity. J Biol Chem 282: 26235-26244. (Pubitemid 47443787)
17. Henneberger C, Papouin T, Oliet SH, Rusakov DA, (2010). Long-term potentiation depends on release of d-serine from astrocytes. Nature 463: 232-236.
18. Hermann GE, Van Meter MJ, Rood JC, Rogers RC, (2009). Proteinase-activated receptors in the nucleus of the solitary tract: evidence for glial-neural interactions in autonomic control of the stomach. J Neurosci 29: 9292-9300.
19. Kollen M, Dutar P, Jouvenceau A, (2008). The magnitude of hippocampal long term depression depends on the synaptic location of activated NR2-containing N-methyl-D-aspartate receptors. Neuroscience 154: 1308-1317.
20. Lee CJ, Mannaioni G, Yuan H, Woo DH, Gingrich MB, Traynelis SF, (2007). Astrocytic control of synaptic NMDA receptors. J Physiol 581: 1057-1081. (Pubitemid 46887980)
21. Li R, Huang FS, Abbas AK, Wigström H, (2007). Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity. BMC Neurosci 8: 55.
22. Lohman RJ, O'Brien TJ, Cocks TM, (2008). Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis. Neurobiol Dis 30: 84-93.
23. Lohman RJ, Jones NC, O'Brien TJ, Cocks TM, (2009). A regulatory role for protease-activated receptor-2 in motivational learning in rats. Neurobiol Learn Mem 92: 301.9.
24. Luo W, Wang Y, Reiser G, (2007). Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev 56: 331-345. (Pubitemid 350176599)
25. Lüscher C, Huber KM, (2010). Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65: 445-459.
26. MacDonald JF, Jackson MF, Beazely MA, (2006). Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 18: 71-84. (Pubitemid 350194079)
27. McNair K, Davies CH, Cobb SR, (2006). Plasticity-related regulation of the hippocampal proteome. Eur J Neurosci 23: 575-580.
28. Noorbakhsh F, Vergnolle N, McArthur JC, Silva C, Vodjgani M, Andrade-Gordon P, et al,. (2006). Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol 174: 7320-7329. (Pubitemid 40705702)
29. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, et al,. (2007). Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203: 425-435.
30. Okada-Ogawa A, Suzuki I, Sessle BJ, Chiang CY, Salter MW, Dostrovsky JO, et al,. (2009). Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms. J Neurosci 29: 11161-11171.
31. Ossovskaya VS, Bunnett NW, (2004). Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621. (Pubitemid 38365493)
32. Peng Y, Zhao J, Gu QH, Chen RQ, Xu Z, Yan JZ, et al,. (2010). Distinct trafficking and expression mechanisms underlie LTP and LTD of NMDA receptor-mediated synaptic responses. Hippocampus 20: 646-658.
33. Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG, (2002). Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett 329: 181-184. (Pubitemid 34880068)
34. 2+-dependent glutamate release. Neuroscience 158: 253-259.
35. Shigetomi E, Bowser DN, Sofroniew MV, Khakh BS, (2008). Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. J Neurosci 28: 6659-6663.
36. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, et al,. (2001). Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 14: 595-608. (Pubitemid 34625987)
37. i-inducing protease-activated receptors (PAR1 and PAR2) in rat astrocytes and C6 glioma cells. Neuroscience 86: 597-609. (Pubitemid 28293936)
38. Wang H, Ubl JJ, Reiser G, (2002). Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signalling. Glia 37: 53-63. (Pubitemid 34103094)
39. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, et al,. (2003). ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 4: 971-982. (Pubitemid 37522054)